Alpha Tau Medical (DRTS) Common Equity (2020 - 2026)
Alpha Tau Medical (DRTS) posted Common Equity of $69.4 million for Q1 2026, down 10.05% sequentially from $77.1 million in Q4 2025, and up 23.13% YoY from $56.3 million in Q1 2025.
Alpha Tau Medical (DRTS) Common Equity (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Common Equity for 7 years, with the latest figure at $69.4 million in Q1 2026.
- Quarterly Common Equity rose 23.13% year-over-year to $69.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.4 million (up 23.13% YoY) and the FY2025 annual result came in at $77.1 million, up 23.03% from the prior year.
- Common Equity fell to $69.4 million in Q1 2026 per DRTS's latest filing, from $77.1 million in the prior quarter.
- Over five years, Common Equity peaked at $108.3 million in Q2 2022 and troughed at $56.3 million in Q1 2025.
- A 5-year average of $84.3 million and a median of $84.5 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2025: Common Equity soared 403.81% in 2022, then decreased 28.76% in 2025.
- Over 5 years, Common Equity stood at $105.7 million in 2022, then dropped by 20.05% to $84.5 million in 2023, then decreased by 25.82% to $62.7 million in 2024, then grew by 23.03% to $77.1 million in 2025, then slipped by 10.05% to $69.4 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $69.4 million, $77.1 million, and $77.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.61 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.17 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.79 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.35 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 757.49 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 44.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.06 Mn |
| Mar 31, 2026 | 69.35 Mn |
| Dec 31, 2025 | 77.10 Mn |
| Sep 30, 2025 | 77.58 Mn |
| Jun 30, 2025 | 86.62 Mn |
| Mar 31, 2025 | 56.33 Mn |
| Dec 31, 2024 | 62.67 Mn |
| Sep 30, 2024 | 69.40 Mn |
| Jun 30, 2024 | 74.02 Mn |
| Mar 31, 2024 | 79.07 Mn |
| Dec 31, 2023 | 84.48 Mn |
| Sep 30, 2023 | 89.85 Mn |
| Jun 30, 2023 | 92.56 Mn |
| Mar 31, 2023 | 99.18 Mn |
| Dec 31, 2022 | 105.66 Mn |
| Sep 30, 2022 | 107.26 Mn |
| Jun 30, 2022 | 108.27 Mn |
| Mar 31, 2022 | 93.99 Mn |
| Dec 31, 2021 | -34.78 Mn |
| Dec 31, 2020 | -8.43 Mn |